These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21141837)

  • 1. Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues.
    Li Y; Tian Y; Rezai T; Prakash A; Lopez MF; Chan DW; Zhang H
    Anal Chem; 2011 Jan; 83(1):240-5. PubMed ID: 21141837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
    Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
    Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis - mass spectrometry.
    Moran AB; Domínguez-Vega E; Nouta J; Pongracz T; de Reijke TM; Wuhrer M; Lageveen-Kammeijer GSM
    J Proteomics; 2021 Apr; 238():104148. PubMed ID: 33618028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples.
    Végvári A; Rezeli M; Häkkinen J; Sihlbom C; Carlsohn E; Malm J; Lilja H; Laurell T; Marko-Varga G
    J Proteomics; 2011 Dec; 75(1):202-10. PubMed ID: 21723425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry-Based Glycoproteomics and Prostate Cancer.
    Gabriele C; Prestagiacomo LE; Cuda G; Gaspari M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on core-fucosylated prostate-specific antigen as a refined biomarker for differentiation of benign prostate hyperplasia and prostate cancer of different aggressiveness.
    Lang R; Rolny V; Leinenbach A; Karl J; Swiatek-de Lange M; Kobold U; Schrader M; Krause H; Mueller M; Vogeser M
    Tumour Biol; 2019 Mar; 41(3):1010428319827223. PubMed ID: 30907281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer.
    Yoneyama T; Ohyama C; Hatakeyama S; Narita S; Habuchi T; Koie T; Mori K; Hidari KI; Yamaguchi M; Suzuki T; Tobisawa Y
    Biochem Biophys Res Commun; 2014 Jun; 448(4):390-6. PubMed ID: 24814705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
    Yoneyama T; Yamamoto H; Sutoh Yoneyama M; Tobisawa Y; Hatakeyama S; Narita T; Kodama H; Momota M; Ito H; Narita S; Tsushima F; Mitsuzuka K; Yoneyama T; Hashimoto Y; Duivenvoorden W; Pinthus JH; Kakeda S; Ito A; Tsuchiya N; Habuchi T; Ohyama C
    Prostate; 2021 Dec; 81(16):1411-1427. PubMed ID: 34549452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression.
    Kawahara R; Recuero S; Srougi M; Leite KRM; Thaysen-Andersen M; Palmisano G
    Mol Cell Proteomics; 2021; 20():100026. PubMed ID: 33127837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia.
    Hsiao CJ; Tzai TS; Chen CH; Yang WH; Chen CH
    Dis Markers; 2016; 2016():8915809. PubMed ID: 27065039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoproteomics: identifying the glycosylation of prostate specific antigen at normal and high isoelectric points by LC-MS/MS.
    Song E; Mayampurath A; Yu CY; Tang H; Mechref Y
    J Proteome Res; 2014 Dec; 13(12):5570-80. PubMed ID: 25327667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-glycosylated clusterin as a sensitive marker for diagnosing early stages of prostate cancer.
    Kazuno S; Fujimura T; Fujime M; Miura Y; Ueno T
    Prostate; 2021 Feb; 81(3):170-181. PubMed ID: 33347638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a prostate specific antigen-based prostate cancer diagnostic assay: preparation of keyhole limpet hemocyanin-conjugated normal and transformed prostate specific antigen fragments.
    Dudkin VY; Miller JS; Dudkina AS; Antczak C; Scheinberg DA; Danishefsky SJ
    J Am Chem Soc; 2008 Oct; 130(41):13598-607. PubMed ID: 18798614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
    Llop E; Peracaula R
    Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.
    Hatano K; Yoneyama T; Hatakeyama S; Tomiyama E; Tsuchiya M; Nishimoto M; Yoshimura K; Miyoshi E; Uemura H; Ohyama C; Nonomura N; Fujita K
    Br J Cancer; 2022 Mar; 126(5):764-770. PubMed ID: 34802050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen.
    Kammeijer GSM; Nouta J; de la Rosette JJMCH; de Reijke TM; Wuhrer M
    Anal Chem; 2018 Apr; 90(7):4414-4421. PubMed ID: 29502397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia.
    Dwek MV; Jenks A; Leathem AJ
    Clin Chim Acta; 2010 Dec; 411(23-24):1935-9. PubMed ID: 20708609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Label-free chronopotentiometric glycoprofiling of prostate specific antigen using sialic acid recognizing lectins.
    Belicky S; Černocká H; Bertok T; Holazova A; Réblová K; Paleček E; Tkac J; Ostatná V
    Bioelectrochemistry; 2017 Oct; 117():89-94. PubMed ID: 28651174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
    Tajiri M; Ohyama C; Wada Y
    Glycobiology; 2008 Jan; 18(1):2-8. PubMed ID: 17956937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.
    Meany DL; Zhang Z; Sokoll LJ; Zhang H; Chan DW
    J Proteome Res; 2009 Feb; 8(2):613-9. PubMed ID: 19035787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.